For: | Niccolini F, Politis M. Neuroimaging in Huntington’s disease. World J Radiol 2014; 6(6): 301-312 [PMID: 24976932 DOI: 10.4329/wjr.v6.i6.301] |
---|---|
URL: | https://www.wjgnet.com/2220-3206/full/v6/i6/301.htm |
Number | Citing Articles |
1 |
Carmen Lopez-Sanchez, Virginio Garcia-Martinez, Joana Poejo, Virginio Garcia-Lopez, Jairo Salazar, Carlos Gutierrez-Merino. Early Reactive A1 Astrocytes Induction by the Neurotoxin 3-Nitropropionic Acid in Rat Brain. International Journal of Molecular Sciences 2020; 21(10): 3609 doi: 10.3390/ijms21103609
|
2 |
Sai Sanwid Pradhan, Sai Swaroop R., Sai Phalguna Kanikaram, Datta Darshan V.M., Ashish Pargaonkar, Rajesh Babu Dandamudi, Venketesh Sivaramakrishnan. Metabolic deregulation associated with aging modulates protein aggregation in the yeast model of Huntington’s disease. Journal of Biomolecular Structure and Dynamics 2024; 42(19): 10521 doi: 10.1080/07391102.2023.2257322
|
3 |
Laura Pont, Fernando Benavente, Joaquim Jaumot, Romà Tauler, Jordi Alberch, Silvia Ginés, José Barbosa, Victoria Sanz‐Nebot. Metabolic profiling for the identification of Huntington biomarkers by on‐line solid‐phase extraction capillary electrophoresis mass spectrometry combined with advanced data analysis tools. ELECTROPHORESIS 2016; 37(5-6): 795 doi: 10.1002/elps.201500378
|
4 |
Tayyabah Yousaf, Heather Wilson, Marios Politis. Nonmotor Parkinson's: The Hidden Face - The Many Hidden Faces. International Review of Neurobiology 2017; 133: 179 doi: 10.1016/bs.irn.2017.05.001
|
5 |
Julie Hamaide, Geert De Groof, Annemie Van der Linden. Neuroplasticity and MRI: A perfect match. NeuroImage 2016; 131: 13 doi: 10.1016/j.neuroimage.2015.08.005
|
6 |
Zhuo Wang, Daniel P. Stefanko, Yumei Guo, William A. Toy, Giselle M. Petzinger, Michael W. Jakowec, Daniel P. Holschneider. Evidence of functional brain reorganization on the basis of blood flow changes in the CAG140 knock-in mouse model of Huntington’s disease. NeuroReport 2016; 27(9): 632 doi: 10.1097/WNR.0000000000000587
|
7 |
Franciele F. Scarante, Melissa A. Ribeiro, Ana F. Almeida-Santos, Francisco S. Guimarães, Alline C. Campos. Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders. Frontiers in Pharmacology 2021; 11 doi: 10.3389/fphar.2020.618065
|
8 |
P. Conforti, D. Besusso, V. D. Bocchi, A. Faedo, E. Cesana, G. Rossetti, V. Ranzani, C. N. Svendsen, L. M. Thompson, M. Toselli, G. Biella, M. Pagani, E. Cattaneo. Faulty neuronal determination and cell polarization are reverted by modulating HD early phenotypes. Proceedings of the National Academy of Sciences 2018; 115(4) doi: 10.1073/pnas.1715865115
|
9 |
Brendan Tan, Rosita Shishegar, Govinda R. Poudel, Alex Fornito, Nellie Georgiou‐Karistianis. Cortical morphometry and neural dysfunction in Huntington’s disease: a review. European Journal of Neurology 2021; 28(4): 1406 doi: 10.1111/ene.14648
|
10 |
Shuai Jin, Lijuan Zhang, Lin Wang. Kaempferol, a potential neuroprotective agent in neurodegenerative diseases: From chemistry to medicine. Biomedicine & Pharmacotherapy 2023; 165: 115215 doi: 10.1016/j.biopha.2023.115215
|
11 |
Heather Wilson, Rosa De Micco, Flavia Niccolini, Marios Politis. Molecular Imaging Markers to Track Huntington’s Disease Pathology. Frontiers in Neurology 2017; 8 doi: 10.3389/fneur.2017.00011
|
12 |
Tayyabah Yousaf, Gennaro Pagano, Heather Wilson, Marios Politis. Neuroimaging of Sleep Disturbances in Movement Disorders. Frontiers in Neurology 2018; 9 doi: 10.3389/fneur.2018.00767
|
13 |
Hongshuai Liu, Chuangchuang Zhang, Jiadi Xu, Jing Jin, Liam Cheng, Xinyuan Miao, Qian Wu, Zhiliang Wei, Peiying Liu, Hanzhang Lu, Peter C M van Zijl, Christopher A Ross, Jun Hua, Wenzhen Duan. Huntingtin silencing delays onset and slows progression of Huntington’s disease: a biomarker study. Brain 2021; 144(10): 3101 doi: 10.1093/brain/awab190
|
14 |
Maria Eugenia Caligiuri, Giuseppe Tradigo, Patrizia Vizza. Using Hybrid Bioimaging Analysis for Rare Neurological Diseases. ACM SIGBioinformatics Record 2023; 12(1): 1 doi: 10.1145/3615362.3615365
|
15 |
Christos Yapijakis. GeNeDis 2016. Advances in Experimental Medicine and Biology 2017; 987: 55 doi: 10.1007/978-3-319-57379-3_6
|
16 |
Mohamed Iqbal J. Management of Traumatic Ulcerations of Lips in a Case of Huntington’s Disease: A Novel Application of Essix Retainer. Journal of Indian Orthodontic Society 2021; 55(4): 415 doi: 10.1177/03015742211023469
|
17 |
Era Taoufik, Georgia Kouroupi, Ourania Zygogianni, Rebecca Matsas. Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models. Open Biology 2018; 8(9) doi: 10.1098/rsob.180138
|
18 |
Ryo Kurokawa, Mariko Kurokawa, Akihiko Mitsutake, Moto Nakaya, Akira Baba, Yasuhiro Nakata, Toshio Moritani, Osamu Abe. Clinical and neuroimaging review of triplet repeat diseases. Japanese Journal of Radiology 2023; 41(2): 115 doi: 10.1007/s11604-022-01343-5
|
19 |
Baijayanta Maiti, Joel S. Perlmutter. Imaging in Movement Disorders. CONTINUUM: Lifelong Learning in Neurology 2023; 29(1): 194 doi: 10.1212/CON.0000000000001210
|
20 |
Christelle Langley, Sarah Gregory, Katie Osborne-Crowley, Claire O'Callaghan, Paul Zeun, Jessica Lowe, Eileanoir B Johnson, Marina Papoutsi, Rachael I Scahill, Geraint Rees, Sarah J Tabrizi, Trevor W Robbins, Barbara Jacquelyn Sahakian. Fronto-striatal circuits for cognitive flexibility in far from onset Huntington’s disease: evidence from the Young Adult Study. Journal of Neurology, Neurosurgery & Psychiatry 2021; 92(2): 143 doi: 10.1136/jnnp-2020-324104
|
21 |
Sebastian Michels, Hans-Georg Buchholz, Florian Rosar, Isabel Heinrich, Manuela A. Hoffmann, Susann Schweiger, Oliver Tüscher, Mathias Schreckenberger. 18F-FDG PET/CT: an unexpected case of Huntington’s disease. BMC Neurology 2019; 19(1) doi: 10.1186/s12883-019-1311-9
|
22 |
Edoardo Rosario de Natale, Heather Wilson, Gennaro Pagano, Marios Politis. Imaging in Movement Disorders: Imaging Applications in Non-Parkinsonian and Other Movement Disorders. International Review of Neurobiology 2018; 143: 213 doi: 10.1016/bs.irn.2018.10.002
|
23 |
Ryan G Lim, Lisa L Salazar, Daniel K Wilton, Alvin R King, Jennifer T Stocksdale, Delaram Sharifabad, Alice L Lau, Beth Stevens, Jack C Reidling, Sara T Winokur, Malcolm S Casale, Leslie M Thompson, Mónica Pardo, A Gerardo García Díaz-Barriga, Marco Straccia, Phil Sanders, Jordi Alberch, Josep M Canals, Julia A Kaye, Mariah Dunlap, Lisa Jo, Hanna May, Elliot Mount, Cliff Anderson-Bergman, Kelly Haston, Steven Finkbeiner, Amanda J Kedaigle, Theresa A Gipson, Ferah Yildirim, Christopher W Ng, Pamela Milani, David E Housman, Ernest Fraenkel, Nicholas D Allen, Paul J Kemp, Ranjit Singh Atwal, Marta Biagioli, James F Gusella, Marcy E MacDonald, Sergey S Akimov, Nicolas Arbez, Jacqueline Stewart, Christopher A Ross, Virginia B Mattis, Colton M Tom, Loren Ornelas, Anais Sahabian, Lindsay Lenaeus, Berhan Mandefro, Dhruv Sareen, Clive N Svendsen. Developmental alterations in Huntington's disease neural cells and pharmacological rescue in cells and mice. Nature Neuroscience 2017; 20(5): 648 doi: 10.1038/nn.4532
|
24 |
Kevin Tipatet, Isla Du Boulay, Hamish Muir, Liam Davison-Gates, Zdenka Ellederová, Andrew Downes. Raman spectroscopy of brain and skin tissue in a minipig model of Huntington's disease. Analytical Methods 2024; 16(2): 253 doi: 10.1039/D3AY00970J
|
25 |
Shanaika J. Devadiga, Sonali S. Bharate. Recent developments in the management of Huntington's disease. Bioorganic Chemistry 2022; 120: 105642 doi: 10.1016/j.bioorg.2022.105642
|
26 |
Oscar H. Del Brutto, Robertino M. Mera, Victor J. Del Brutto, Mark J. Sedler. The bicaudate index inversely associates with performance in the Montreal Cognitive Assessment (MoCA) in older adults living in rural Ecuador. The Atahualpa project. International Journal of Geriatric Psychiatry 2016; 31(8): 944 doi: 10.1002/gps.4419
|
27 |
Andrea Sturchio, Andrew P. Duker, Ignacio Muñoz-Sanjuan, Alberto J. Espay. Precision Medicine in Neurodegenerative Disorders, Part II. Handbook of Clinical Neurology 2023; 193: 171 doi: 10.1016/B978-0-323-85555-6.00003-5
|
28 |
Karen Ring, Robert O’Brien, Ningzhe Zhang, Lisa M. Ellerby. Patient-Specific Stem Cells. 2017; : 115 doi: 10.1201/9781315402185-7
|
29 |
Roberto D. V. S. Morais, Marina Sogorb-González, Citlali Bar, Nikki C. Timmer, M. Leontien Van der Bent, Morgane Wartel, Astrid Vallès. Functional Intercellular Transmission of miHTT via Extracellular Vesicles: An In Vitro Proof-of-Mechanism Study. Cells 2022; 11(17): 2748 doi: 10.3390/cells11172748
|
30 |
Stefano Patassini, Paul Begley, Jingshu Xu, Stephanie J. Church, Suzanne J. Reid, Eric H. Kim, Maurice A. Curtis, Mike Dragunow, Henry J. Waldvogel, Russell G. Snell, Richard D. Unwin, Richard L.M. Faull, Garth J.S. Cooper. Metabolite mapping reveals severe widespread perturbation of multiple metabolic processes in Huntington's disease human brain. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2016; 1862(9): 1650 doi: 10.1016/j.bbadis.2016.06.002
|
31 |
Santosh S. Bhujbal, Minal M Kad, Vinita C. Patole. Recent diagnostic techniques for the detection of Alzheimer’s disease: a short review. Irish Journal of Medical Science (1971 -) 2023; 192(5): 2417 doi: 10.1007/s11845-022-03244-y
|
32 |
Lorenzo Rocchi, Flavia Niccolini, Marios Politis. Recent imaging advances in neurology. Journal of Neurology 2015; 262(9): 2182 doi: 10.1007/s00415-015-7711-x
|
33 |
Marco Cavallo, Antonietta Sergi, Marco Pagani. Cognitive and social cognition deficits in Huntington’s disease differ between the prodromal and the manifest stages of the condition: A scoping review of recent evidence. British Journal of Clinical Psychology 2022; 61(2): 214 doi: 10.1111/bjc.12337
|
34 |
Maria V. Soloveva, Sharna D. Jamadar, Govinda Poudel, Nellie Georgiou-Karistianis. A critical review of brain and cognitive reserve in Huntington’s disease. Neuroscience & Biobehavioral Reviews 2018; 88: 155 doi: 10.1016/j.neubiorev.2018.03.003
|
35 |
Elizabeth Frances McKiernan, John Tiernan O’Brien. 7T MRI for neurodegenerative dementias in vivo: a systematic review of the literature. Journal of Neurology, Neurosurgery & Psychiatry 2017; 88(7): 564 doi: 10.1136/jnnp-2016-315022
|
36 |
Flavia Niccolini, Marios Politis. A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism. European Journal of Nuclear Medicine and Molecular Imaging 2016; 43(12): 2244 doi: 10.1007/s00259-016-3464-8
|
37 |
Alexandrina S. Nikova, Georgios Sioutas, Konstantinos Kotopoulos, Dimitar Ganchev, Varvara Chatzipaulou, Theodossios Birbilis. The Clock Is Ticking – Brain Atrophy in Case of Acute Trauma?. Korean Journal of Neurotrauma 2019; 15(2): 117 doi: 10.13004/kjnt.2019.15.e35
|
38 |
E.H. Kim, N. Mehrabi, L.J. Tippett, H.J. Waldvogel, R.L.M. Faull. The Cerebral Cortex in Neurodegenerative and Neuropsychiatric Disorders. 2017; : 195 doi: 10.1016/B978-0-12-801942-9.00008-2
|
39 |
Sai S. Pradhan, Sai M. Thota, Saiswaroop Rajaratnam, Sai K. S. Bhagavatham, Sujith K. Pulukool, Sriram Rathnakumar, Kanikaram S. Phalguna, Rajesh B. Dandamudi, Ashish Pargaonkar, Prasanth Joseph, E. V. Joshy, Venketesh Sivaramakrishnan. Integrated multi-omics analysis of Huntington disease identifies pathways that modulate protein aggregation. Disease Models & Mechanisms 2022; 15(10) doi: 10.1242/dmm.049492
|
40 |
Michael G. Erkkinen, Mee-Ohk Kim, Michael D. Geschwind. Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. Cold Spring Harbor Perspectives in Biology 2018; 10(4): a033118 doi: 10.1101/cshperspect.a033118
|
41 |
Maria Eugenia Caligiuri, Patrizia Vizza, Ferdinando Squitieri, Giuseppe Lucio Cascini, Umberto Sabatini, Pierangelo Veltri. Hybrid PET/MRI Analysis in the Juvenile Huntington Disease Evaluation. 2023 International Workshop on Biomedical Applications, Technologies and Sensors (BATS) 2023; : 95 doi: 10.1109/BATS59463.2023.10303018
|
42 |
Heather Wilson, George Dervenoulas, Marios Politis. Imaging in Movement Disorders: Imaging in Atypical Parkinsonism and Familial Movement Disorders. International Review of Neurobiology 2018; 142: 335 doi: 10.1016/bs.irn.2018.09.006
|
43 |
Joseph Jankovic, Mark Hallett, Michael S. Okun, Cynthia Comella, Stanley Fahn, Jennifer Goldman. Principles and Practice of Movement Disorders. 2021; : 371 doi: 10.1016/B978-0-323-31071-0.00013-5
|
44 |
Carmen Lopez-Sanchez, Joana Poejo, Virginio Garcia-Lopez, Jairo Salazar, Virginio Garcia-Martinez, Carlos Gutierrez-Merino. Kaempferol prevents the activation of complement C3 protein and the generation of reactive A1 astrocytes that mediate rat brain degeneration induced by 3-nitropropionic acid. Food and Chemical Toxicology 2022; 164: 113017 doi: 10.1016/j.fct.2022.113017
|
45 |
Yi Hong, Lauren J. O'Donnell, Peter Savadjiev, Fan Zhang, Demian Wassermann, Ofer Pasternak, Hans Johnson, Jane Paulsen, Jean‐Paul Vonsattel, Nikos Makris, Carl F. Westin, Yogesh Rathi. Genetic load determines atrophy in hand cortico‐striatal pathways in presymptomatic Huntington's disease. Human Brain Mapping 2018; 39(10): 3871 doi: 10.1002/hbm.24217
|
46 |
Akshay Nair, Eileanoir B. Johnson, Sarah Gregory, Katherine Osborne-Crowley, Paul Zeun, Rachael I. Scahill, Jessica Lowe, Marina Papoutsi, Stefano Palminteri, Robb B. Rutledge, Geraint Rees, Sarah J. Tabrizi. Aberrant Striatal Value Representation in Huntington's Disease Gene Carriers 25 Years Before Onset. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 2021; 6(9): 910 doi: 10.1016/j.bpsc.2020.12.015
|
47 |
Parneet Kaur, Arunachalam Muthuraman, Manjinder Kaur. The Implications of Angiotensin-Converting Enzymes and Their Modulators in Neurodegenerative Disorders: Current and Future Perspectives. ACS Chemical Neuroscience 2015; 6(4): 508 doi: 10.1021/cn500363g
|
48 |
Heather Wilson, Marios Politis. Imaging in Movement Disorders: Imaging in Atypical Parkinsonism and Familial Movement Disorders. International Review of Neurobiology 2018; 142: 289 doi: 10.1016/bs.irn.2018.08.007
|
49 |
Patrick A. Lewis, Jennifer E. Spillane. The Molecular and Clinical Pathology of Neurodegenerative Disease. 2019; : 193 doi: 10.1016/B978-0-12-811069-0.00006-9
|
50 |
Gennaro Pagano, Flavia Niccolini, Marios Politis. Current status of PET imaging in Huntington’s disease. European Journal of Nuclear Medicine and Molecular Imaging 2016; 43(6): 1171 doi: 10.1007/s00259-016-3324-6
|
51 |
J. Stricker-Shaver, A. Novati, L. Yu-Taeger, H. P. Nguyen. Polyglutamine Disorders. Advances in Experimental Medicine and Biology 2018; 1049: 29 doi: 10.1007/978-3-319-71779-1_2
|
52 |
Carmen López-Sánchez, Ricardo Lagoa, Joana Poejo, Virginio García-López, Virginio García-Martínez, Carlos Gutierrez-Merino. An Update of Kaempferol Protection against Brain Damage Induced by Ischemia-Reperfusion and by 3-Nitropropionic Acid. Molecules 2024; 29(4): 776 doi: 10.3390/molecules29040776
|
53 |
Xiao-ge Liu, Shuai Lu, Dong-qun Liu, Lun Zhang, Ling-xiao Zhang, Xiao-lin Yu, Rui-tian Liu. ScFv-conjugated superparamagnetic iron oxide nanoparticles for MRI-based diagnosis in transgenic mouse models of Parkinson’s and Huntington’s diseases. Brain Research 2019; 1707: 141 doi: 10.1016/j.brainres.2018.11.034
|
54 |
Christopher J. Heald, Asha Sarma, Jeffrey R. Sachs, Michael E. Zapadka, Tamison Jewett, Paul M. Bunch. Practical Genetics for the Neuroradiologist: Adding Value in Neurogenetic Disease. Academic Radiology 2022; 29: S1 doi: 10.1016/j.acra.2020.12.021
|
55 |
Maria del C. Valdés Hernández, Janna Abu‐Hussain, Xinyi Qiu, Josef Priller, Mario Parra Rodríguez, Mariana Pino, Sandra Báez, Agustín Ibáñez. Structural neuroimaging differentiates vulnerability from disease manifestation in colombian families with Huntington's disease. Brain and Behavior 2019; 9(8) doi: 10.1002/brb3.1343
|
56 |
Anita MY Goh, Pierre Wibawa, Samantha M Loi, Mark Walterfang, Dennis Velakoulis, Jeffrey CL Looi. Huntington’s disease: Neuropsychiatric manifestations of Huntington’s disease. Australasian Psychiatry 2018; 26(4): 366 doi: 10.1177/1039856218791036
|